MDX010
Showing 176 - 196 of 196
Prostate Cancer, Tumor Metastasis Trial in United States (MDX-010)
Completed
- Prostate Cancer
- Neoplasm Metastasis
-
Los Angeles, California
- +13 more
Aug 14, 2014
Advanced Melanoma Trial in United States (Ipilimumab, Carboplatin, Paclitaxel)
Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- gp100 antigen
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Melanoma (Skin) Trial (gp100:209-217(210M) peptide vaccine, gp100:280-288(288V) peptide vaccine, incomplete Freund's adjuvant)
Withdrawn
- Melanoma (Skin)
- gp100:209-217(210M) peptide vaccine
- +3 more
- (no location specified)
May 14, 2013
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +61 more
- ipilimumab
- therapeutic allogeneic lymphocytes
-
La Jolla, California
- +4 more
Mar 26, 2013
Melanoma (Skin) Trial run by the CC (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)
Completed
- Melanoma (Skin)
- gp100 antigen
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 21, 2012
Kidney Cancer Trial run by the CC (ipilimumab)
Completed
- Kidney Cancer
- ipilimumab
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Mar 14, 2012
Prostate Cancer Trial in United States (MDX-010 / MDX-010 + Docetaxel)
Completed
- Prostate Cancer
- MDX-010 / MDX-010 + Docetaxel
-
Tucson, Arizona
- +10 more
Jun 23, 2011
Melanoma Trial in United States (MDX-010 (CTLA-4))
Completed
- Melanoma
- MDX-010 (CTLA-4)
-
Tucson, Arizona
- +8 more
Jan 20, 2011
Melanoma, Metastases Trial in Worldwide (MDX-010 (anti-CTLA4) mAb, MDX-1379 (gp100) Melanoma Peptide Vaccine)
Completed
- Melanoma
- Metastases
- MDX-010 (anti-CTLA4) monoclonal antibody
- MDX-1379 (gp100) Melanoma Peptide Vaccine
-
Tucson, Arizona
- +208 more
Jun 29, 2011
Malignant Melanoma Trial in United States (MDX-010)
Completed
- Malignant Melanoma
- MDX-010
-
Tucson, Arizona
- +3 more
Apr 23, 2010
Long-term Data Collection for Subjects in MDX-010 Studies
Completed
- Metastatic Melanoma
-
Tuscon, Arizona
- +10 more
Apr 23, 2010
Melanoma Trial in Worldwide (ipilimumab (MDX-010, BMS-734016), Ipilimumab)
Completed
- Melanoma
- ipilimumab (MDX-010, BMS-734016)
- Ipilimumab
-
Tucson, Arizona
- +61 more
Feb 27, 2010